Probiotics synergized with conventional regimen in managing Parkinson’s disease

Parkinson’s disease (PD) is mainly managed by pharmacological therapy (e.g., Benserazide and dopamine agonists). However, prolonged use of these drugs would gradually diminish their dopaminergic effect. Gut dysbiosis was observed in some patients with PD, suggesting close association between the gut...

Full description

Saved in:
Bibliographic Details
Published inNPJ Parkinson's Disease Vol. 8; no. 1; p. 62
Main Authors Sun, Hairong, Zhao, Feiyan, Liu, Yuanyuan, Ma, Teng, Jin, Hao, Quan, Keyu, Leng, Bing, Zhao, Junwu, Yuan, Xiaoling, Li, Zhenguang, Li, Fang, Kwok, Lai-Yu, Zhang, Shukun, Sun, Zhihong, Zhang, Jinbiao, Zhang, Heping
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 24.05.2022
Nature Publishing Group
Nature Portfolio
Subjects
692/617/375/1718
692/699/375/365/1718
Biomedical and Life Sciences
Biomedicine
Dopamine
Neurology
Neurosciences
Parkinson's disease
Probiotics
Online AccessGet full text

Cover

Abstract Parkinson’s disease (PD) is mainly managed by pharmacological therapy (e.g., Benserazide and dopamine agonists). However, prolonged use of these drugs would gradually diminish their dopaminergic effect. Gut dysbiosis was observed in some patients with PD, suggesting close association between the gut microbiome and PD. Probiotics modulate the host’s gut microbiota beneficially. A 3-month randomized, double-blind, placebo-controlled clinical trial was conducted to investigate the beneficial effect of probiotic co-administration in patients with PD. Eighty-two PD patients were recruited and randomly divided into probiotic [ n  = 48; Bifidobacterium animalis subsp. lactis Probio-M8 (Probio-M8), Benserazide, dopamine agonists] and placebo ( n  = 34; placebo, Benserazide, dopamine agonists) groups. Finally, 45 and 29 patients from Probio-M8 and placebo groups provided complete fecal and serum samples for further omics analysis, respectively. The results showed that Probio-M8 co-administration conferred added benefits by improving sleep quality, alleviating anxiety, and gastrointestinal symptoms. Metagenomic analysis showed that, after the intervention, there were significantly more species-level genome bins (SGBs) of Bifidobacterium animalis , Ruminococcaceae , and Lachnospira , while less Lactobacillus fermentum and Klebsiella oxytoca in Probio-M8 group ( P  < 0.05). Interestingly, Lactobacillus fermentum correlated positively with the scores of UPDRS-III, HAMA, HAMD-17, and negatively with MMSE. Klebsiella oxytoca correlated negatively with feces hardness. Moreover, co-administering Probio-M8 increased SGBs involved in tryptophan degradation, gamma-aminobutyric acid, short-chain fatty acids, and secondary bile acid biosynthesis, as well as serum acetic acid and dopamine levels ( P  < 0.05). Taken together, Probio-M8 synergized with the conventional regimen and strengthened the clinical efficacy in managing PD, accompanied by modifications of the host’s gut microbiome, gut microbial metabolic potential, and serum metabolites.
AbstractList Abstract Parkinson’s disease (PD) is mainly managed by pharmacological therapy (e.g., Benserazide and dopamine agonists). However, prolonged use of these drugs would gradually diminish their dopaminergic effect. Gut dysbiosis was observed in some patients with PD, suggesting close association between the gut microbiome and PD. Probiotics modulate the host’s gut microbiota beneficially. A 3-month randomized, double-blind, placebo-controlled clinical trial was conducted to investigate the beneficial effect of probiotic co-administration in patients with PD. Eighty-two PD patients were recruited and randomly divided into probiotic [n = 48; Bifidobacterium animalis subsp. lactis Probio-M8 (Probio-M8), Benserazide, dopamine agonists] and placebo (n = 34; placebo, Benserazide, dopamine agonists) groups. Finally, 45 and 29 patients from Probio-M8 and placebo groups provided complete fecal and serum samples for further omics analysis, respectively. The results showed that Probio-M8 co-administration conferred added benefits by improving sleep quality, alleviating anxiety, and gastrointestinal symptoms. Metagenomic analysis showed that, after the intervention, there were significantly more species-level genome bins (SGBs) of Bifidobacterium animalis, Ruminococcaceae, and Lachnospira, while less Lactobacillus fermentum and Klebsiella oxytoca in Probio-M8 group (P < 0.05). Interestingly, Lactobacillus fermentum correlated positively with the scores of UPDRS-III, HAMA, HAMD-17, and negatively with MMSE. Klebsiella oxytoca correlated negatively with feces hardness. Moreover, co-administering Probio-M8 increased SGBs involved in tryptophan degradation, gamma-aminobutyric acid, short-chain fatty acids, and secondary bile acid biosynthesis, as well as serum acetic acid and dopamine levels (P < 0.05). Taken together, Probio-M8 synergized with the conventional regimen and strengthened the clinical efficacy in managing PD, accompanied by modifications of the host’s gut microbiome, gut microbial metabolic potential, and serum metabolites.
Abstract Parkinson’s disease (PD) is mainly managed by pharmacological therapy (e.g., Benserazide and dopamine agonists). However, prolonged use of these drugs would gradually diminish their dopaminergic effect. Gut dysbiosis was observed in some patients with PD, suggesting close association between the gut microbiome and PD. Probiotics modulate the host’s gut microbiota beneficially. A 3-month randomized, double-blind, placebo-controlled clinical trial was conducted to investigate the beneficial effect of probiotic co-administration in patients with PD. Eighty-two PD patients were recruited and randomly divided into probiotic [ n  = 48; Bifidobacterium animalis subsp. lactis Probio-M8 (Probio-M8), Benserazide, dopamine agonists] and placebo ( n  = 34; placebo, Benserazide, dopamine agonists) groups. Finally, 45 and 29 patients from Probio-M8 and placebo groups provided complete fecal and serum samples for further omics analysis, respectively. The results showed that Probio-M8 co-administration conferred added benefits by improving sleep quality, alleviating anxiety, and gastrointestinal symptoms. Metagenomic analysis showed that, after the intervention, there were significantly more species-level genome bins (SGBs) of Bifidobacterium animalis , Ruminococcaceae , and Lachnospira , while less Lactobacillus fermentum and Klebsiella oxytoca in Probio-M8 group ( P  < 0.05). Interestingly, Lactobacillus fermentum correlated positively with the scores of UPDRS-III, HAMA, HAMD-17, and negatively with MMSE. Klebsiella oxytoca correlated negatively with feces hardness. Moreover, co-administering Probio-M8 increased SGBs involved in tryptophan degradation, gamma-aminobutyric acid, short-chain fatty acids, and secondary bile acid biosynthesis, as well as serum acetic acid and dopamine levels ( P  < 0.05). Taken together, Probio-M8 synergized with the conventional regimen and strengthened the clinical efficacy in managing PD, accompanied by modifications of the host’s gut microbiome, gut microbial metabolic potential, and serum metabolites.
Parkinson’s disease (PD) is mainly managed by pharmacological therapy (e.g., Benserazide and dopamine agonists). However, prolonged use of these drugs would gradually diminish their dopaminergic effect. Gut dysbiosis was observed in some patients with PD, suggesting close association between the gut microbiome and PD. Probiotics modulate the host’s gut microbiota beneficially. A 3-month randomized, double-blind, placebo-controlled clinical trial was conducted to investigate the beneficial effect of probiotic co-administration in patients with PD. Eighty-two PD patients were recruited and randomly divided into probiotic [ n  = 48; Bifidobacterium animalis subsp. lactis Probio-M8 (Probio-M8), Benserazide, dopamine agonists] and placebo ( n  = 34; placebo, Benserazide, dopamine agonists) groups. Finally, 45 and 29 patients from Probio-M8 and placebo groups provided complete fecal and serum samples for further omics analysis, respectively. The results showed that Probio-M8 co-administration conferred added benefits by improving sleep quality, alleviating anxiety, and gastrointestinal symptoms. Metagenomic analysis showed that, after the intervention, there were significantly more species-level genome bins (SGBs) of Bifidobacterium animalis , Ruminococcaceae , and Lachnospira , while less Lactobacillus fermentum and Klebsiella oxytoca in Probio-M8 group ( P  < 0.05). Interestingly, Lactobacillus fermentum correlated positively with the scores of UPDRS-III, HAMA, HAMD-17, and negatively with MMSE. Klebsiella oxytoca correlated negatively with feces hardness. Moreover, co-administering Probio-M8 increased SGBs involved in tryptophan degradation, gamma-aminobutyric acid, short-chain fatty acids, and secondary bile acid biosynthesis, as well as serum acetic acid and dopamine levels ( P  < 0.05). Taken together, Probio-M8 synergized with the conventional regimen and strengthened the clinical efficacy in managing PD, accompanied by modifications of the host’s gut microbiome, gut microbial metabolic potential, and serum metabolites.
Parkinson's disease (PD) is mainly managed by pharmacological therapy (e.g., Benserazide and dopamine agonists). However, prolonged use of these drugs would gradually diminish their dopaminergic effect. Gut dysbiosis was observed in some patients with PD, suggesting close association between the gut microbiome and PD. Probiotics modulate the host's gut microbiota beneficially. A 3-month randomized, double-blind, placebo-controlled clinical trial was conducted to investigate the beneficial effect of probiotic co-administration in patients with PD. Eighty-two PD patients were recruited and randomly divided into probiotic [n = 48; Bifidobacterium animalis subsp. lactis Probio-M8 (Probio-M8), Benserazide, dopamine agonists] and placebo (n = 34; placebo, Benserazide, dopamine agonists) groups. Finally, 45 and 29 patients from Probio-M8 and placebo groups provided complete fecal and serum samples for further omics analysis, respectively. The results showed that Probio-M8 co-administration conferred added benefits by improving sleep quality, alleviating anxiety, and gastrointestinal symptoms. Metagenomic analysis showed that, after the intervention, there were significantly more species-level genome bins (SGBs) of Bifidobacterium animalis, Ruminococcaceae, and Lachnospira, while less Lactobacillus fermentum and Klebsiella oxytoca in Probio-M8 group (P < 0.05). Interestingly, Lactobacillus fermentum correlated positively with the scores of UPDRS-III, HAMA, HAMD-17, and negatively with MMSE. Klebsiella oxytoca correlated negatively with feces hardness. Moreover, co-administering Probio-M8 increased SGBs involved in tryptophan degradation, gamma-aminobutyric acid, short-chain fatty acids, and secondary bile acid biosynthesis, as well as serum acetic acid and dopamine levels (P < 0.05). Taken together, Probio-M8 synergized with the conventional regimen and strengthened the clinical efficacy in managing PD, accompanied by modifications of the host's gut microbiome, gut microbial metabolic potential, and serum metabolites.
ArticleNumber 62
Author Ma, Teng
Li, Fang
Jin, Hao
Quan, Keyu
Zhao, Feiyan
Zhang, Shukun
Sun, Zhihong
Leng, Bing
Kwok, Lai-Yu
Li, Zhenguang
Zhao, Junwu
Zhang, Jinbiao
Zhang, Heping
Liu, Yuanyuan
Yuan, Xiaoling
Sun, Hairong
Author_xml – sequence: 1
  givenname: Hairong
  surname: Sun
  fullname: Sun, Hairong
  organization: Inner Mongolia Key Laboratory of Dairy Biotechnology and Engineering; Key Laboratory of Dairy Products Processing, Ministry of Agriculture and Rural Affairs; Key Laboratory of Dairy Biotechnology and Engineering, Ministry of Education, Inner Mongolia Agricultural University, Department of neurology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University
– sequence: 2
  givenname: Feiyan
  orcidid: 0000-0002-7360-5436
  surname: Zhao
  fullname: Zhao, Feiyan
  organization: Inner Mongolia Key Laboratory of Dairy Biotechnology and Engineering; Key Laboratory of Dairy Products Processing, Ministry of Agriculture and Rural Affairs; Key Laboratory of Dairy Biotechnology and Engineering, Ministry of Education, Inner Mongolia Agricultural University
– sequence: 3
  givenname: Yuanyuan
  surname: Liu
  fullname: Liu, Yuanyuan
  organization: Department of neurology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University
– sequence: 4
  givenname: Teng
  surname: Ma
  fullname: Ma, Teng
  organization: Inner Mongolia Key Laboratory of Dairy Biotechnology and Engineering; Key Laboratory of Dairy Products Processing, Ministry of Agriculture and Rural Affairs; Key Laboratory of Dairy Biotechnology and Engineering, Ministry of Education, Inner Mongolia Agricultural University
– sequence: 5
  givenname: Hao
  orcidid: 0000-0003-2965-0739
  surname: Jin
  fullname: Jin, Hao
  organization: Inner Mongolia Key Laboratory of Dairy Biotechnology and Engineering; Key Laboratory of Dairy Products Processing, Ministry of Agriculture and Rural Affairs; Key Laboratory of Dairy Biotechnology and Engineering, Ministry of Education, Inner Mongolia Agricultural University
– sequence: 6
  givenname: Keyu
  surname: Quan
  fullname: Quan, Keyu
  organization: Inner Mongolia Key Laboratory of Dairy Biotechnology and Engineering; Key Laboratory of Dairy Products Processing, Ministry of Agriculture and Rural Affairs; Key Laboratory of Dairy Biotechnology and Engineering, Ministry of Education, Inner Mongolia Agricultural University
– sequence: 7
  givenname: Bing
  surname: Leng
  fullname: Leng, Bing
  organization: Department of neurology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University
– sequence: 8
  givenname: Junwu
  surname: Zhao
  fullname: Zhao, Junwu
  organization: Department of neurology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University
– sequence: 9
  givenname: Xiaoling
  surname: Yuan
  fullname: Yuan, Xiaoling
  organization: Department of Neurology, Liaocheng People’s Hospital and Liaocheng Clinical School of Taishan Medical University
– sequence: 10
  givenname: Zhenguang
  surname: Li
  fullname: Li, Zhenguang
  organization: Department of neurology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University
– sequence: 11
  givenname: Fang
  surname: Li
  fullname: Li, Fang
  organization: Department of Neurology, The First Affiliated Hospital of Jinzhou Medical University
– sequence: 12
  givenname: Lai-Yu
  surname: Kwok
  fullname: Kwok, Lai-Yu
  organization: Inner Mongolia Key Laboratory of Dairy Biotechnology and Engineering; Key Laboratory of Dairy Products Processing, Ministry of Agriculture and Rural Affairs; Key Laboratory of Dairy Biotechnology and Engineering, Ministry of Education, Inner Mongolia Agricultural University
– sequence: 13
  givenname: Shukun
  surname: Zhang
  fullname: Zhang, Shukun
  organization: Department of Pathology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University
– sequence: 14
  givenname: Zhihong
  surname: Sun
  fullname: Sun, Zhihong
  organization: Inner Mongolia Key Laboratory of Dairy Biotechnology and Engineering; Key Laboratory of Dairy Products Processing, Ministry of Agriculture and Rural Affairs; Key Laboratory of Dairy Biotechnology and Engineering, Ministry of Education, Inner Mongolia Agricultural University
– sequence: 15
  givenname: Jinbiao
  surname: Zhang
  fullname: Zhang, Jinbiao
  email: drzhangjinbiao@163.com
  organization: Department of neurology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University
– sequence: 16
  givenname: Heping
  surname: Zhang
  fullname: Zhang, Heping
  email: hepingdd@vip.sina.com
  organization: Inner Mongolia Key Laboratory of Dairy Biotechnology and Engineering; Key Laboratory of Dairy Products Processing, Ministry of Agriculture and Rural Affairs; Key Laboratory of Dairy Biotechnology and Engineering, Ministry of Education, Inner Mongolia Agricultural University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35610236$$D View this record in MEDLINE/PubMed
BookMark eNp9kt1qFTEQx4NUbK19AS9kwRtvVvM52b0RpPhRKFhBr0NOdrLNcU9Skz2VeuVr-Ho-ifFsra0XQiAh85_fZCb_h2QvpoiEPGb0OaOie1EkU4K1lPOWUsF1C_fIARdatB1Veu_WeZ8clbKmlDIJXa_oA7IvFDDKBRyQD2c5rUKagytNuYqYx_ANh-ZrmM8bl-IlxjmkaKcm4xg2GJsQm42NdgxxbM5s_hxiSfHn9x-lGUJBW_ARue_tVPDoej8kn968_nj8rj19__bk-NVp65Skc-uxV6pHpkCwQWqPQq8kDE4i5QOg14qCFFQw0B1zg0NpfQfeg9NKQyfFITlZuEOya3ORw8bmK5NsMLuLlEdjc-1rQjNoJwAkUC2c9N72FlYoup4p2YlB28p6ubAutqsN1mJxzna6A70bieHcjOnS9ExQ3usKeHYNyOnLFstsNqE4nCYbMW2L4QB18pyqvkqf_iNdp22uI96pOlWXElXFF5XLqZSM_uYxjJrfBjCLAUw1gNkZwEBNenK7jZuUP99dBWIRlBqKI-a_tf-D_QXGmr5i
CitedBy_id crossref_primary_10_1007_s11910_023_01312_z
crossref_primary_10_1007_s40263_024_01073_4
crossref_primary_10_3390_nu15071737
crossref_primary_10_14802_jmd_22220
crossref_primary_10_1016_j_tifs_2023_06_013
crossref_primary_10_26599_FSHW_2022_9250250
crossref_primary_10_3746_pnf_2023_28_4_502
crossref_primary_10_1039_D3FO00728F
crossref_primary_10_3389_fmicb_2024_1272062
crossref_primary_10_3390_ijms232213665
crossref_primary_10_1016_j_biopha_2023_114468
crossref_primary_10_3390_life14050559
crossref_primary_10_1007_s00394_022_03042_3
crossref_primary_10_1039_D3FO02307A
crossref_primary_10_3389_fcimb_2023_1114364
crossref_primary_10_3390_microorganisms12020370
crossref_primary_10_1016_j_lfs_2024_122748
crossref_primary_10_1007_s12035_024_04038_2
crossref_primary_10_4103_1673_5374_382223
crossref_primary_10_3390_ijms23147503
crossref_primary_10_1124_pharmrev_122_000674
crossref_primary_10_1002_mco2_420
crossref_primary_10_3390_ijms232012289
crossref_primary_10_1016_j_heliyon_2024_e32004
crossref_primary_10_3389_fneur_2024_1407241
crossref_primary_10_1007_s12035_023_03340_9
crossref_primary_10_1016_j_clnu_2024_05_036
crossref_primary_10_1016_j_ctim_2024_103045
crossref_primary_10_1038_s41538_022_00169_9
crossref_primary_10_3390_nu14214678
crossref_primary_10_1128_msystems_00331_23
crossref_primary_10_1128_msystems_01013_23
crossref_primary_10_1002_jsfa_13509
crossref_primary_10_1021_acs_jafc_2c07606
crossref_primary_10_3390_nu15010051
crossref_primary_10_1002_mnfr_202300461
crossref_primary_10_1038_s41598_024_59250_w
crossref_primary_10_1186_s13099_023_00536_1
crossref_primary_10_1007_s12035_024_03988_x
crossref_primary_10_1016_j_celrep_2023_112199
crossref_primary_10_1016_j_jare_2024_03_005
crossref_primary_10_1038_s41392_024_01743_1
crossref_primary_10_1016_j_jfma_2022_09_010
Cites_doi 10.1186/s12934-021-01589-0
10.1159/000331911
10.1038/nmeth.1923
10.1038/s41531-021-00156-z
10.1016/j.cell.2020.08.007
10.1073/pnas.1819154116
10.1186/s13063-019-3389-1
10.2147/CIA.S106284
10.1038/s41564-018-0337-x
10.1056/NEJMoa0809335
10.1186/s13059-019-1891-0
10.1186/s13568-020-01014-6
10.3389/fphar.2018.01354
10.1038/ismej.2015.188
10.3389/fnagi.2021.676827
10.1016/j.cell.2016.11.018
10.3168/jds.2019-18049
10.1093/ajcn/nqab078
10.1001/jamaneurol.2019.4611
10.1101/gr.186072.114
10.1016/j.pep.2013.10.018
10.1016/j.neulet.2018.03.064
10.1186/s12877-020-01574-z
10.1038/s41531-020-0112-6
10.1016/j.lfs.2020.117345
10.1016/j.ebiom.2019.05.064
10.1038/nature09944
10.1038/s41398-021-01309-7
10.3390/brainsci10040206
10.1002/ana.25982
10.1038/s41366-021-00888-1
10.3390/metabo7040062
10.1016/j.clnu.2018.05.018
10.1038/s41385-018-0042-3
10.1016/j.biopsych.2013.05.001
10.1212/WNL.0000000000003127
10.1002/mnfr.201801012
10.1038/nrgastro.2014.66
10.1212/WNL.0000000000011652
10.1038/ismej.2017.126
10.1038/s41531-016-0002-0
10.1093/gerona/glaa090
10.1186/s12937-016-0198-1
10.1038/s41564-018-0307-3
10.1152/ajpgi.00283.2019
10.1136/gutjnl-2015-309618
10.1128/Spectrum.00859-21
10.1186/s13024-021-00439-2
10.1042/bj20030002
10.1007/s00394-021-02543-x
10.1016/j.chom.2020.12.012
10.1186/1471-2105-11-119
10.1017/neu.2014.33
10.1093/bioinformatics/btp352
10.1038/s41467-018-07826-2
10.1016/j.ynstr.2021.100294
10.1007/s00726-017-2409-2
10.18632/aging.102810
10.1007/s00401-014-1343-6
10.1152/physrev.00018.2018
10.1016/j.pharmthera.2021.107861
10.1002/mds.22197
10.1016/j.clnu.2018.09.010
10.1152/ajpgi.00058.2020
10.1038/s41586-019-1688-z
10.1002/mds.26424
10.1053/j.gastro.2016.02.014
10.1007/s13679-016-0191-1
10.1002/mds.28052
10.1038/s41467-019-10927-1
10.1038/s41467-021-21669-4
10.5056/jnm17105
10.1007/s11011-009-9139-4
10.1016/j.jns.2009.09.015
10.1016/j.molcel.2020.03.006
10.1038/s41392-020-00357-7
10.1109/IPDPS.2019.00041
ContentType Journal Article
Copyright The Author(s) 2022
2022. The Author(s).
The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2022
– notice: 2022. The Author(s).
– notice: The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
NPM
AAYXX
CITATION
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1038/s41531-022-00327-6
DatabaseName SpringerOpen
PubMed
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
CrossRef

PubMed
Publicly Available Content Database

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: C6C
  name: SpringerOpen
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2373-8057
EndPage 62
ExternalDocumentID oai_doaj_org_article_d7c36646073c4ffa9a6be38915483d7a
10_1038_s41531_022_00327_6
35610236
Genre Journal Article
GrantInformation_xml – fundername: Inner Mongolia Science & Technology Major Projects (grant number ZDZX2018018)
– fundername: National Natural Science Foundation of China (National Science Foundation of China)
  grantid: 31720103911
  funderid: https://doi.org/10.13039/501100001809
– fundername: National Natural Science Foundation of China (National Science Foundation of China)
  grantid: 31720103911
– fundername: ;
– fundername: ;
  grantid: 31720103911
GroupedDBID 0R~
3V.
53G
5VS
7X7
8FI
8FJ
AAJSJ
ABUWG
ACGFS
ACSMW
ADBBV
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BCNDV
BENPR
BPHCQ
BVXVI
C6C
CCPQU
EBLON
EBS
EMOBN
FYUFA
GROUPED_DOAJ
HMCUK
HYE
M~E
NAO
NO~
OK1
PGMZT
PIMPY
PQQKQ
PROAC
RNT
RPM
SNYQT
UKHRP
NPM
AAYXX
CITATION
7XB
8FK
AZQEC
DWQXO
K9.
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c540t-fe9559e15631d47fe37b46dc4e02d6ef7506430316781cdce4af86ff6c7576843
IEDL.DBID RPM
ISSN 2373-8057
IngestDate Tue Oct 22 15:13:14 EDT 2024
Tue Sep 17 21:15:13 EDT 2024
Thu Aug 15 22:23:42 EDT 2024
Thu Oct 10 15:57:07 EDT 2024
Fri Aug 23 03:33:55 EDT 2024
Sat Sep 28 08:19:13 EDT 2024
Fri Oct 11 20:46:06 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2022. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c540t-fe9559e15631d47fe37b46dc4e02d6ef7506430316781cdce4af86ff6c7576843
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-7360-5436
0000-0003-2965-0739
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130297/
PMID 35610236
PQID 2668568553
PQPubID 2041921
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_d7c36646073c4ffa9a6be38915483d7a
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9130297
proquest_miscellaneous_2669502059
proquest_journals_2668568553
crossref_primary_10_1038_s41531_022_00327_6
pubmed_primary_35610236
springer_journals_10_1038_s41531_022_00327_6
PublicationCentury 2000
PublicationDate 2022-05-24
PublicationDateYYYYMMDD 2022-05-24
PublicationDate_xml – month: 05
  year: 2022
  text: 2022-05-24
  day: 24
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: United States
PublicationTitle NPJ Parkinson's Disease
PublicationTitleAbbrev npj Parkinsons Dis
PublicationTitleAlternate NPJ Parkinsons Dis
PublicationYear 2022
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References Tamtaji (CR24) 2019; 38
Tan (CR57) 2021; 89
Hill (CR19) 2014; 11
Kobayashi (CR67) 2021; 118
Wallen (CR5) 2020; 6
Nair (CR1) 2018; 24
Deng (CR40) 2020; 12
Hsieh (CR34) 2020; 10
Aho (CR47) 2019; 44
Kang (CR79) 2019; 7
Mueller, Muhlack, Woitalla (CR74) 2011; 37
Sampson (CR10) 2016; 167
Darzi (CR87) 2016; 10
Georgescu (CR26) 2016; 11
Haghikia (CR64) 2017; 49
Zhang (CR31) 2020; 11
Jameson (CR11) 2020; 78
Ibrahim (CR27) 2020; 15
Unterhauser (CR55) 2019; 116
Feng, Ao, Peng (CR60) 2018; 9
Ochoa-Reparaz, Kasper (CR4) 2016; 5
Borzabadi (CR28) 2018; 21
Boehme (CR12) 2021; 1
Cirstea (CR6) 2020; 35
Strandwitz (CR15) 2019; 4
Mallick (CR88) 2019; 10
Browne (CR38) 2019; 20
Zhang (CR45) 2021; 114
Tanes (CR48) 2021; 29
Bhattarai, Kashyap (CR2) 2020; 319
Romano (CR7) 2021; 7
Jang (CR54) 2018; 11
Olm (CR84) 2017; 11
Feng (CR17) 2020; 245
Ma (CR43) 2021; 14
Faraco (CR65) 2019; 574
dos Santos (CR51) 2009; 24
Kaur (CR49) 2019; 63
Caldovic, Tuchman (CR63) 2003; 372
Parks (CR82) 2015; 25
Zhang, Ni (CR52) 2014; 94
Noble (CR53) 2021; 11
Arumugam (CR50) 2011; 473
Li (CR81) 2009; 25
Dinan, Stanton, Cryan (CR77) 2013; 74
Zhao (CR16) 2021; 140
Houser, Tansey (CR36) 2017; 3
Uemura (CR73) 2009; 287
Wang (CR35) 2021; 6
CR80
Postuma (CR69) 2015; 30
van Kessel (CR14) 2019; 10
Gefenaite (CR75) 2020; 20
Wen (CR18) 2021; 13
Otstlund-Lagerstrom (CR39) 2016; 15
Barichella (CR23) 2016; 87
Mullin (CR58) 2020; 77
Hyatt (CR86) 2010; 11
Crooks (CR59) 2018; 675
Muller (CR61) 2020; 318
Valles-Colomer (CR32) 2019; 4
Ozcan (CR72) 2015; 27
Zhang (CR29) 2020; 103
Olanow (CR37) 2009; 361
Cassani (CR22) 2011; 57
Kim (CR41) 2021; 76
Mao (CR62) 2021; 226
Handakas (CR66) 2021; 45
Rekdal (CR13) 2019; 364
Langmead, Salzberg (CR78) 2012; 9
Haaxma (CR71) 2008; 23
Kuai (CR76) 2021; 20
Fang (CR21) 2020; 10
Holmqvist (CR9) 2014; 128
Hsieh (CR20) 2020; 10
Vandeputte (CR46) 2016; 65
Tan (CR25) 2021; 96
Mars (CR44) 2020; 182
Palsson (CR70) 2016; 150
Lew (CR42) 2019; 38
Sinclair (CR56) 2021; 12
Cao (CR30) 2021; 60
Kreit (CR68) 2017; 364
Cryan (CR8) 2019; 99
Wood, Lu, Langmead (CR85) 2019; 20
Chong, Xia (CR33) 2017; 7
Gries (CR3) 2021; 16
Liu (CR83) 2021; 9
A Haghikia (327_CR64) 2017; 49
H Li (327_CR81) 2009; 25
A Liu (327_CR83) 2021; 9
AT Nair (327_CR1) 2018; 24
J Kreit (327_CR68) 2017; 364
K Unterhauser (327_CR55) 2019; 116
A Ibrahim (327_CR27) 2020; 15
X Zhang (327_CR45) 2021; 114
M Muller (327_CR61) 2020; 318
A Kaur (327_CR49) 2019; 63
M Gries (327_CR3) 2021; 16
L Caldovic (327_CR63) 2003; 372
TG Dinan (327_CR77) 2013; 74
L Otstlund-Lagerstrom (327_CR39) 2016; 15
S Borzabadi (327_CR28) 2018; 21
CS Kim (327_CR41) 2021; 76
VM Rekdal (327_CR13) 2019; 364
M Arumugam (327_CR50) 2011; 473
T Ozcan (327_CR72) 2015; 27
XY Kuai (327_CR76) 2021; 20
TH Hsieh (327_CR34) 2020; 10
AH Tan (327_CR57) 2021; 89
B Langmead (327_CR78) 2012; 9
CA Haaxma (327_CR71) 2008; 23
ZD Wallen (327_CR5) 2020; 6
S Mullin (327_CR58) 2020; 77
E Cassani (327_CR22) 2011; 57
T Ma (327_CR43) 2021; 14
Y Bhattarai (327_CR2) 2020; 319
OS Palsson (327_CR70) 2016; 150
TR Sampson (327_CR10) 2016; 167
T-H Hsieh (327_CR20) 2020; 10
PD Browne (327_CR38) 2019; 20
KG Jameson (327_CR11) 2020; 78
E Handakas (327_CR66) 2021; 45
SP van Kessel (327_CR14) 2019; 10
DE Wood (327_CR85) 2019; 20
T Mueller (327_CR74) 2011; 37
C Tanes (327_CR48) 2021; 29
S Holmqvist (327_CR9) 2014; 128
VTE Aho (327_CR47) 2019; 44
K Zhang (327_CR52) 2014; 94
W Zhang (327_CR29) 2020; 103
HM Jang (327_CR54) 2018; 11
RB Postuma (327_CR69) 2015; 30
C Hill (327_CR19) 2014; 11
AH Tan (327_CR25) 2021; 96
M Barichella (327_CR23) 2016; 87
G Gefenaite (327_CR75) 2020; 20
Y Darzi (327_CR87) 2016; 10
OR Tamtaji (327_CR24) 2019; 38
EE Noble (327_CR53) 2021; 11
S Romano (327_CR7) 2021; 7
MC Houser (327_CR36) 2017; 3
XY Mao (327_CR62) 2021; 226
327_CR80
J Ochoa-Reparaz (327_CR4) 2016; 5
JF Cryan (327_CR8) 2019; 99
MR Olm (327_CR84) 2017; 11
P Strandwitz (327_CR15) 2019; 4
D Georgescu (327_CR26) 2016; 11
JN Cao (327_CR30) 2021; 60
CW Olanow (327_CR37) 2009; 361
J Kobayashi (327_CR67) 2021; 118
JC Zhang (327_CR31) 2020; 11
M Boehme (327_CR12) 2021; 1
X Wen (327_CR18) 2021; 13
EF dos Santos (327_CR51) 2009; 24
DWD Kang (327_CR79) 2019; 7
HY Deng (327_CR40) 2020; 12
X Fang (327_CR21) 2020; 10
YS Feng (327_CR17) 2020; 245
J Chong (327_CR33) 2017; 7
SA Crooks (327_CR59) 2018; 675
XY Zhao (327_CR16) 2021; 140
H Mallick (327_CR88) 2019; 10
D Hyatt (327_CR86) 2010; 11
RAT Mars (327_CR44) 2020; 182
MS Cirstea (327_CR6) 2020; 35
M Valles-Colomer (327_CR32) 2019; 4
D Vandeputte (327_CR46) 2016; 65
Y Wang (327_CR35) 2021; 6
Y Uemura (327_CR73) 2009; 287
G Faraco (327_CR65) 2019; 574
LC Lew (327_CR42) 2019; 38
DH Parks (327_CR82) 2015; 25
E Sinclair (327_CR56) 2021; 12
W Feng (327_CR60) 2018; 9
References_xml – volume: 20
  year: 2021
  ident: CR76
  article-title: Evaluation of fecal microbiota transplantation in Parkinson’s disease patients with constipation
  publication-title: Microb. Cell Factories
  doi: 10.1186/s12934-021-01589-0
  contributor:
    fullname: Kuai
– volume: 37
  start-page: 183
  year: 2011
  end-page: 187
  ident: CR74
  article-title: Pain perception, pain drug therapy and health status in patients with Parkinson’s disease
  publication-title: Neuroepidemiology
  doi: 10.1159/000331911
  contributor:
    fullname: Woitalla
– volume: 9
  start-page: 357
  year: 2012
  end-page: U54.
  ident: CR78
  article-title: Fast gapped-read alignment with Bowtie 2
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.1923
  contributor:
    fullname: Salzberg
– volume: 7
  start-page: 13
  year: 2021
  ident: CR7
  article-title: Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation
  publication-title: Npj Parkinsons Dis.
  doi: 10.1038/s41531-021-00156-z
  contributor:
    fullname: Romano
– volume: 182
  start-page: 1460
  year: 2020
  ident: CR44
  article-title: Longitudinal multi-omics reveals subset-specific mechanisms underlying irritable bowel syndrome
  publication-title: Cell
  doi: 10.1016/j.cell.2020.08.007
  contributor:
    fullname: Mars
– volume: 116
  start-page: 3774
  year: 2019
  end-page: 3783
  ident: CR55
  article-title: Klebsiella oxytoca enterotoxins tilimycin and tilivalline have distinct host DNA-damaging and microtubule-stabilizing activities
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1819154116
  contributor:
    fullname: Unterhauser
– volume: 20
  year: 2019
  ident: CR38
  article-title: Probiotics in pregnancy: protocol of a double-blind randomized controlled pilot trial for pregnant women with depression and anxiety (PIP pilot trial)
  publication-title: Trials
  doi: 10.1186/s13063-019-3389-1
  contributor:
    fullname: Browne
– volume: 11
  start-page: 1601
  year: 2016
  end-page: 1608
  ident: CR26
  article-title: Nonmotor gastrointestinal disorders in older patients with Parkinson’s disease: is there hope?
  publication-title: Clin. Interven. Aging
  doi: 10.2147/CIA.S106284
  contributor:
    fullname: Georgescu
– volume: 4
  start-page: 623
  year: 2019
  end-page: 632
  ident: CR32
  article-title: The neuroactive potential of the human gut microbiota in quality of life and depression
  publication-title: Nat. Microbiol.
  doi: 10.1038/s41564-018-0337-x
  contributor:
    fullname: Valles-Colomer
– ident: CR80
– volume: 361
  start-page: 1268
  year: 2009
  end-page: 1278
  ident: CR37
  article-title: A double-blind, delayed-start trial of rasagiline in Parkinson’s diseas
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa0809335
  contributor:
    fullname: Olanow
– volume: 20
  year: 2019
  ident: CR85
  article-title: Improved metagenomic analysis with Kraken 2
  publication-title: Genome Biol.
  doi: 10.1186/s13059-019-1891-0
  contributor:
    fullname: Langmead
– volume: 10
  year: 2020
  ident: CR21
  article-title: Therapeutic effect of GLP-1 engineered strain on mice model of Alzheimer’s disease and Parkinson’s disease
  publication-title: Amb. Express
  doi: 10.1186/s13568-020-01014-6
  contributor:
    fullname: Fang
– volume: 9
  start-page: 1354
  year: 2018
  ident: CR60
  article-title: Gut microbiota, short-chain fatty acids, and herbal medicines
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2018.01354
  contributor:
    fullname: Peng
– volume: 10
  start-page: 1025
  year: 2016
  end-page: 1028
  ident: CR87
  article-title: Towards biome-specific analysis of meta-omics data
  publication-title: ISME J.
  doi: 10.1038/ismej.2015.188
  contributor:
    fullname: Darzi
– volume: 13
  start-page: 676827
  year: 2021
  ident: CR18
  article-title: Acupuncture-related therapies for Parkinson’s disease: a meta-analysis and qualitative review
  publication-title: Front. Aging Neurosci.
  doi: 10.3389/fnagi.2021.676827
  contributor:
    fullname: Wen
– volume: 167
  start-page: 1469
  year: 2016
  ident: CR10
  article-title: Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease
  publication-title: Cell
  doi: 10.1016/j.cell.2016.11.018
  contributor:
    fullname: Sampson
– volume: 103
  start-page: 8791
  year: 2020
  end-page: 8795
  ident: CR29
  article-title: Short communication: modulation of fatty acid metabolism improves oxygen tolerance of Bifidobacterium animalis ssp. lactis Probio-M8
  publication-title: J. Dairy Sci.
  doi: 10.3168/jds.2019-18049
  contributor:
    fullname: Zhang
– volume: 114
  start-page: 429
  year: 2021
  end-page: 440
  ident: CR45
  article-title: Diet quality, gut microbiota, and microRNAs associated with mild cognitive impairment in middle-aged and elderly Chinese population
  publication-title: Am. J. Clin. Nutr.
  doi: 10.1093/ajcn/nqab078
  contributor:
    fullname: Zhang
– volume: 77
  start-page: 427
  year: 2020
  end-page: 434
  ident: CR58
  article-title: Ambroxol for the treatment of patients with Parkinson disease with and without glucocerebrosidase gene mutations: a nonrandomized, noncontrolled trial
  publication-title: JAMA Neurol.
  doi: 10.1001/jamaneurol.2019.4611
  contributor:
    fullname: Mullin
– volume: 25
  start-page: 1043
  year: 2015
  end-page: 1055
  ident: CR82
  article-title: CheckM: assessing the quality of microbial genomes recovered from isolates, single cells, and metagenomes
  publication-title: Genome Res.
  doi: 10.1101/gr.186072.114
  contributor:
    fullname: Parks
– volume: 11
  start-page: 14
  year: 2020
  ident: CR31
  article-title: Probiotics maintain the intestinal microbiome homeostasis of the sailors during a long sea voyage
  publication-title: Gut Microbes
  contributor:
    fullname: Zhang
– volume: 94
  start-page: 33
  year: 2014
  end-page: 39
  ident: CR52
  article-title: Tyrosine decarboxylase from Lactobacillus brevis: Soluble expression and characterization
  publication-title: Protein Expr. Purif.
  doi: 10.1016/j.pep.2013.10.018
  contributor:
    fullname: Ni
– volume: 675
  start-page: 116
  year: 2018
  end-page: 119
  ident: CR59
  article-title: Carnitine levels and mutations in the SLC22A5 gene in Faroes patients with Parkinson’s disease
  publication-title: Neurosci. Lett.
  doi: 10.1016/j.neulet.2018.03.064
  contributor:
    fullname: Crooks
– volume: 20
  start-page: 181
  year: 2020
  ident: CR75
  article-title: Longitudinal association between housing accessibility and activities of daily living: the role of self-efficacy and control in people ageing with Parkinson’s disease
  publication-title: BMC Geriatr.
  doi: 10.1186/s12877-020-01574-z
  contributor:
    fullname: Gefenaite
– volume: 6
  start-page: 12
  year: 2020
  ident: CR5
  article-title: Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens
  publication-title: Npj Parkinsons Dis.
  doi: 10.1038/s41531-020-0112-6
  contributor:
    fullname: Wallen
– volume: 245
  start-page: 10
  year: 2020
  ident: CR17
  article-title: The benefits and mechanisms of exercise training for Parkinson’s disease
  publication-title: Life Sci.
  doi: 10.1016/j.lfs.2020.117345
  contributor:
    fullname: Feng
– volume: 44
  start-page: 691
  year: 2019
  end-page: 707
  ident: CR47
  article-title: Gut microbiota in Parkinson’s disease: temporal stability and relations to disease progression
  publication-title: Ebiomedicine
  doi: 10.1016/j.ebiom.2019.05.064
  contributor:
    fullname: Aho
– volume: 473
  start-page: 174
  year: 2011
  end-page: 180
  ident: CR50
  article-title: Enterotypes of the human gut microbiome
  publication-title: Nature
  doi: 10.1038/nature09944
  contributor:
    fullname: Arumugam
– volume: 11
  year: 2021
  ident: CR53
  article-title: Gut microbial taxa elevated by dietary sugar disrupt memory function
  publication-title: Transl. Psychiatry
  doi: 10.1038/s41398-021-01309-7
  contributor:
    fullname: Noble
– volume: 10
  start-page: 206
  year: 2020
  ident: CR20
  article-title: Probiotics alleviate the progressive deterioration of motor functions in a mouse model of Parkinson’s disease
  publication-title: Brain Sci.
  doi: 10.3390/brainsci10040206
  contributor:
    fullname: Hsieh
– volume: 89
  start-page: 546
  year: 2021
  end-page: 559
  ident: CR57
  article-title: Gut microbial ecosystem in Parkinson disease: new clinicobiological insights from multi-omics
  publication-title: Ann. Neurol.
  doi: 10.1002/ana.25982
  contributor:
    fullname: Tan
– volume: 45
  start-page: 2252
  year: 2021
  end-page: 2260
  ident: CR66
  article-title: Cord blood metabolic signatures predictive of childhood overweight and rapid growth
  publication-title: Int. J. Obes.
  doi: 10.1038/s41366-021-00888-1
  contributor:
    fullname: Handakas
– volume: 1
  start-page: 666
  year: 2021
  end-page: 67
  ident: CR12
  article-title: Microbiota from young mice counteracts selective age-associated behavioral deficits
  publication-title: Food Behav. Res.
  contributor:
    fullname: Boehme
– volume: 118
  start-page: 8
  year: 2021
  ident: CR67
  article-title: Cholestenone functions as an antibiotic against Helicobacter pylori by inhibiting biosynthesis of the cell wall component CGL
  publication-title: Proc. Natl Acad. Sci. USA
  contributor:
    fullname: Kobayashi
– volume: 7
  start-page: 10
  year: 2017
  ident: CR33
  article-title: Computational approaches for integrative analysis of the metabolome and microbiome
  publication-title: Metabolites
  doi: 10.3390/metabo7040062
  contributor:
    fullname: Xia
– volume: 38
  start-page: 1031
  year: 2019
  end-page: 1035
  ident: CR24
  article-title: Clinical and metabolic response to probiotic administration in people with Parkinson’s disease: a randomized, double-blind, placebo-controlled trial
  publication-title: Clin. Nutr.
  doi: 10.1016/j.clnu.2018.05.018
  contributor:
    fullname: Tamtaji
– volume: 11
  start-page: 1386
  year: 2018
  end-page: 1397
  ident: CR54
  article-title: Evidence for interplay among antibacterial-induced gut microbiota disturbance, neuro-inflammation, and anxiety in mice
  publication-title: Mucosal Immunol.
  doi: 10.1038/s41385-018-0042-3
  contributor:
    fullname: Jang
– volume: 74
  start-page: 720
  year: 2013
  end-page: 726
  ident: CR77
  article-title: Psychobiotics: a novel class of psychotropic
  publication-title: Biol. Psychiatry
  doi: 10.1016/j.biopsych.2013.05.001
  contributor:
    fullname: Cryan
– volume: 87
  start-page: 1274
  year: 2016
  end-page: 1280
  ident: CR23
  article-title: Probiotics and prebiotic fiber for constipation associated with Parkinson disease: an RCT
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000003127
  contributor:
    fullname: Barichella
– volume: 15
  start-page: 17
  year: 2020
  ident: CR27
  article-title: Multi-strain probiotics (Hexbio) containing MCP BCMC strains improved constipation and gut motility in Parkinson’s disease: a randomised controlled trial
  publication-title: PLos ONE
  contributor:
    fullname: Ibrahim
– volume: 63
  start-page: 8
  year: 2019
  ident: CR49
  article-title: Physical inaccessibility of a resistant starch shifts mouse gut microbiota to butyrogenic firmicutes
  publication-title: Mol. Nutr. Food Res.
  doi: 10.1002/mnfr.201801012
  contributor:
    fullname: Kaur
– volume: 11
  start-page: 506
  year: 2014
  end-page: 514
  ident: CR19
  article-title: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
  publication-title: Nat. Rev. Gastroenterol. Hepatol.
  doi: 10.1038/nrgastro.2014.66
  contributor:
    fullname: Hill
– volume: 96
  start-page: E772
  year: 2021
  end-page: E782
  ident: CR25
  article-title: Probiotics for constipation in Parkinson disease: a randomized placebo-controlled study
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000011652
  contributor:
    fullname: Tan
– volume: 11
  start-page: 2864
  year: 2017
  end-page: 2868
  ident: CR84
  article-title: dRep: a tool for fast and accurate genomic comparisons that enables improved genome recovery from metagenomes through de-replication
  publication-title: Isme J.
  doi: 10.1038/ismej.2017.126
  contributor:
    fullname: Olm
– volume: 3
  start-page: 9
  year: 2017
  ident: CR36
  article-title: The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?
  publication-title: Npj Parkinsons Dis.
  doi: 10.1038/s41531-016-0002-0
  contributor:
    fullname: Tansey
– volume: 21
  start-page: 289
  year: 2018
  end-page: 295
  ident: CR28
  article-title: The effects of probiotic supplementation on gene expression related to inflammation, insulin and lipid in patients with Parkinson’s disease: a randomized, double-blind, placebo-controlled trial
  publication-title: Arch. Iran. Med.
  contributor:
    fullname: Borzabadi
– volume: 76
  start-page: 32
  year: 2021
  end-page: 40
  ident: CR41
  article-title: Probiotic supplementation improves cognitive function and mood with changes in gut microbiota in community-dwelling older adults: a randomized, double-blind, placebo-controlled, multicenter trial
  publication-title: J. Gerontol. Ser. A Biol. Sci. Med. Sci.
  doi: 10.1093/gerona/glaa090
  contributor:
    fullname: Kim
– volume: 57
  start-page: 117
  year: 2011
  end-page: 121
  ident: CR22
  article-title: Use of probiotics for the treatment of constipation in Parkinson’s disease patients
  publication-title: Minerva Gastroenterol. Dietol.
  contributor:
    fullname: Cassani
– volume: 15
  start-page: 80
  year: 2016
  ident: CR39
  article-title: Probiotic administration among free-living older adults: a double blinded, randomized, placebo-controlled clinical trial
  publication-title: Nutr. J.
  doi: 10.1186/s12937-016-0198-1
  contributor:
    fullname: Otstlund-Lagerstrom
– volume: 4
  start-page: 396
  year: 2019
  end-page: 403
  ident: CR15
  article-title: GABA-modulating bacteria of the human gut microbiota
  publication-title: Nat. Microbiol.
  doi: 10.1038/s41564-018-0307-3
  contributor:
    fullname: Strandwitz
– volume: 140
  start-page: 11
  year: 2021
  ident: CR16
  article-title: Baicalein alleviates depression-like behavior in rotenone- induced Parkinson’s disease model in mice through activating the BDNF/TrkB/CREB pathway
  publication-title: Biomed. Pharmacother.
  contributor:
    fullname: Zhao
– volume: 318
  start-page: G361
  year: 2020
  end-page: G369
  ident: CR61
  article-title: Distal colonic transit is linked to gut microbiota diversity and microbial fermentation in humans with slow colonic transit
  publication-title: Am. J. Physiol.Gastrointest. Liver Physiol.
  doi: 10.1152/ajpgi.00283.2019
  contributor:
    fullname: Muller
– volume: 65
  start-page: 57
  year: 2016
  end-page: 62
  ident: CR46
  article-title: Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates
  publication-title: Gut
  doi: 10.1136/gutjnl-2015-309618
  contributor:
    fullname: Vandeputte
– volume: 9
  start-page: e0085921
  year: 2021
  ident: CR83
  article-title: Adjunctive probiotics alleviates asthmatic symptoms via modulating the gut microbiome and serum metabolome
  publication-title: Microbiol. Spectr.
  doi: 10.1128/Spectrum.00859-21
  contributor:
    fullname: Liu
– volume: 16
  year: 2021
  ident: CR3
  article-title: Parkinson mice show functional and molecular changes in the gut long before motoric disease onset
  publication-title: Mol. Neurodegeneration
  doi: 10.1186/s13024-021-00439-2
  contributor:
    fullname: Gries
– volume: 372
  start-page: 279
  year: 2003
  end-page: 290
  ident: CR63
  article-title: N-acetylglutamate and its changing role through evolution
  publication-title: Biochem. J.
  doi: 10.1042/bj20030002
  contributor:
    fullname: Tuchman
– volume: 60
  start-page: 3757
  year: 2021
  end-page: 3769
  ident: CR30
  article-title: Bifidobacterium Lactis Probio-M8 regulates gut microbiota to alleviate Alzheimer’s disease in the APP/PS1 mouse model
  publication-title: Eur. J. Nutr.
  doi: 10.1007/s00394-021-02543-x
  contributor:
    fullname: Cao
– volume: 29
  start-page: 394
  year: 2021
  ident: CR48
  article-title: Role of dietary fiber in the recovery of the human gut microbiome and its metabolome
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2020.12.012
  contributor:
    fullname: Tanes
– volume: 11
  year: 2010
  ident: CR86
  article-title: Prodigal: prokaryotic gene recognition and translation initiation site identification
  publication-title: BMC Bioinforma.
  doi: 10.1186/1471-2105-11-119
  contributor:
    fullname: Hyatt
– volume: 27
  start-page: 33
  year: 2015
  end-page: 37
  ident: CR72
  article-title: The relation of sexual dysfunction to depression and anxiety in patients with Parkinson’s disease
  publication-title: Acta Neuropsychiatr.
  doi: 10.1017/neu.2014.33
  contributor:
    fullname: Ozcan
– volume: 25
  start-page: 2078
  year: 2009
  end-page: 2079
  ident: CR81
  article-title: The sequence alignment/map format and SAMtools
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp352
  contributor:
    fullname: Li
– volume: 10
  start-page: 11
  year: 2019
  ident: CR14
  article-title: Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson’s disease.
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-018-07826-2
  contributor:
    fullname: van Kessel
– volume: 14
  start-page: 10
  year: 2021
  ident: CR43
  article-title: Probiotic consumption relieved human stress and anxiety symptoms possibly via modulating the neuroactive potential of the gut microbiota
  publication-title: Neurobiol. Stress
  doi: 10.1016/j.ynstr.2021.100294
  contributor:
    fullname: Ma
– volume: 49
  start-page: 1111
  year: 2017
  end-page: 1121
  ident: CR64
  article-title: The role of L-arginine/L-homoarginine/nitric oxide pathway for aortic distensibility and intima-media thickness in stroke patients
  publication-title: Amino Acids
  doi: 10.1007/s00726-017-2409-2
  contributor:
    fullname: Haghikia
– volume: 12
  start-page: 4010
  year: 2020
  end-page: 4039
  ident: CR40
  article-title: Efficacy of probiotics on cognition, and biomarkers of inflammation and oxidative stress in adults with Alzheimer’s disease or mild cognitive impairment - a meta-analysis of randomized controned trials
  publication-title: Aging
  doi: 10.18632/aging.102810
  contributor:
    fullname: Deng
– volume: 128
  start-page: 805
  year: 2014
  end-page: 820
  ident: CR9
  article-title: Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-014-1343-6
  contributor:
    fullname: Holmqvist
– volume: 99
  start-page: 1877
  year: 2019
  end-page: 2013
  ident: CR8
  article-title: The microbiota-gut-brain axis
  publication-title: Physiol. Rev.
  doi: 10.1152/physrev.00018.2018
  contributor:
    fullname: Cryan
– volume: 226
  start-page: 22
  year: 2021
  ident: CR62
  article-title: Dietary nutrition for neurological disease therapy: current status and future direction
  publication-title: Pharmacol. Therapeutics
  doi: 10.1016/j.pharmthera.2021.107861
  contributor:
    fullname: Mao
– volume: 23
  start-page: 1707
  year: 2008
  end-page: 1717
  ident: CR71
  article-title: Comparison of a timed motor test battery to the Unified Parkinson’s Disease Rating Scale-III in Parkinson’s disease
  publication-title: Mov. Disord.
  doi: 10.1002/mds.22197
  contributor:
    fullname: Haaxma
– volume: 38
  start-page: 2053
  year: 2019
  end-page: 2064
  ident: CR42
  article-title: Probiotic Lactobacillus plantarum P8 alleviated stress and anxiety while enhancing memory and cognition in stressed adults: a randomised, double-blind, placebo-controlled study
  publication-title: Clin. Nutr.
  doi: 10.1016/j.clnu.2018.09.010
  contributor:
    fullname: Lew
– volume: 319
  start-page: G529
  year: 2020
  end-page: G540
  ident: CR2
  article-title: Parkinson’s disease: are gut microbes involved?
  publication-title: Am. J. Physiol. Gastrointest. Liver Physiol.
  doi: 10.1152/ajpgi.00058.2020
  contributor:
    fullname: Kashyap
– volume: 574
  start-page: 686
  year: 2019
  ident: CR65
  article-title: Dietary salt promotes cognitive impairment through tau phosphorylation
  publication-title: Nature
  doi: 10.1038/s41586-019-1688-z
  contributor:
    fullname: Faraco
– volume: 30
  start-page: 1591
  year: 2015
  end-page: 1599.
  ident: CR69
  article-title: MDS clinical diagnostic criteria for Parkinson’s disease
  publication-title: Mov. Disord.
  doi: 10.1002/mds.26424
  contributor:
    fullname: Postuma
– volume: 364
  start-page: 9
  year: 2017
  ident: CR68
  article-title: Microbial catabolism of sterols: focus on the enzymes that transform the sterol 3 beta-hydroxy-5-en into 3-keto-4-en
  publication-title: Fems Microbiol. Lett.
  contributor:
    fullname: Kreit
– volume: 150
  start-page: 1481
  year: 2016
  end-page: 1491
  ident: CR70
  article-title: Development and validation of the Rome IV Diagnostic Questionnaire for adults
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2016.02.014
  contributor:
    fullname: Palsson
– volume: 5
  start-page: 51
  year: 2016
  end-page: 64
  ident: CR4
  article-title: The second brain: is the gut microbiota a link between obesity and central nervous system disorders?
  publication-title: Curr. Obes. Rep.
  doi: 10.1007/s13679-016-0191-1
  contributor:
    fullname: Kasper
– volume: 35
  start-page: 1208
  year: 2020
  end-page: 1217
  ident: CR6
  article-title: Microbiota composition and metabolism are associated with gut function in Parkinson’s disease
  publication-title: Mov. Disord.
  doi: 10.1002/mds.28052
  contributor:
    fullname: Cirstea
– volume: 10
  year: 2019
  ident: CR88
  article-title: Predictive metabolomic profiling of microbial communities using amplicon or metagenomic sequences
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-019-10927-1
  contributor:
    fullname: Mallick
– volume: 364
  start-page: 1055
  year: 2019
  ident: CR13
  article-title: Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism
  publication-title: Science
  contributor:
    fullname: Rekdal
– volume: 10
  start-page: 13
  year: 2020
  ident: CR34
  article-title: Probiotics alleviate the progressive deterioration of motor functions in a mouse model of Parkinson’s disease
  publication-title: Brain Sci.
  doi: 10.3390/brainsci10040206
  contributor:
    fullname: Hsieh
– volume: 12
  start-page: 9
  year: 2021
  ident: CR56
  article-title: Metabolomics of sebum reveals lipid dysregulation in Parkinson’s disease.
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-021-21669-4
  contributor:
    fullname: Sinclair
– volume: 24
  start-page: 30
  year: 2018
  end-page: 42
  ident: CR1
  article-title: Gut microbiota dysfunction as reliable non-invasive early diagnostic biomarkers in the pathophysiology of Parkinson’s disease: a critical review
  publication-title: J. Neurogastroenterol. Motil.
  doi: 10.5056/jnm17105
  contributor:
    fullname: Nair
– volume: 24
  start-page: 257
  year: 2009
  end-page: 269
  ident: CR51
  article-title: Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in ParkinsonCs disease
  publication-title: Metab. Brain Dis.
  doi: 10.1007/s11011-009-9139-4
  contributor:
    fullname: dos Santos
– volume: 287
  start-page: 36
  year: 2009
  end-page: 40
  ident: CR73
  article-title: Validation of the Parkinson’s disease sleep scale in Japanese patients: a comparison study using the Pittsburgh Sleep Quality Index, the Epworth Sleepiness Scale and Polysomnography
  publication-title: J. Neurol. Sci.
  doi: 10.1016/j.jns.2009.09.015
  contributor:
    fullname: Uemura
– volume: 7
  start-page: 13
  year: 2019
  ident: CR79
  article-title: MetaBAT 2: an adaptive binning algorithm for robust and efficient genome reconstruction from metagenome assemblies
  publication-title: Peerj
  contributor:
    fullname: Kang
– volume: 78
  start-page: 577
  year: 2020
  end-page: 583
  ident: CR11
  article-title: Toward understanding microbiome-neuronal signaling
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2020.03.006
  contributor:
    fullname: Jameson
– volume: 6
  start-page: 20
  year: 2021
  ident: CR35
  article-title: Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota
  publication-title: Signal Transduct. Target. Ther.
  doi: 10.1038/s41392-020-00357-7
  contributor:
    fullname: Wang
– volume: 27
  start-page: 33
  year: 2015
  ident: 327_CR72
  publication-title: Acta Neuropsychiatr.
  doi: 10.1017/neu.2014.33
  contributor:
    fullname: T Ozcan
– volume: 11
  start-page: 14
  year: 2020
  ident: 327_CR31
  publication-title: Gut Microbes
  contributor:
    fullname: JC Zhang
– volume: 9
  start-page: e0085921
  year: 2021
  ident: 327_CR83
  publication-title: Microbiol. Spectr.
  doi: 10.1128/Spectrum.00859-21
  contributor:
    fullname: A Liu
– ident: 327_CR80
  doi: 10.1109/IPDPS.2019.00041
– volume: 128
  start-page: 805
  year: 2014
  ident: 327_CR9
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-014-1343-6
  contributor:
    fullname: S Holmqvist
– volume: 9
  start-page: 357
  year: 2012
  ident: 327_CR78
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.1923
  contributor:
    fullname: B Langmead
– volume: 11
  start-page: 506
  year: 2014
  ident: 327_CR19
  publication-title: Nat. Rev. Gastroenterol. Hepatol.
  doi: 10.1038/nrgastro.2014.66
  contributor:
    fullname: C Hill
– volume: 10
  start-page: 13
  year: 2020
  ident: 327_CR34
  publication-title: Brain Sci.
  doi: 10.3390/brainsci10040206
  contributor:
    fullname: TH Hsieh
– volume: 7
  start-page: 10
  year: 2017
  ident: 327_CR33
  publication-title: Metabolites
  doi: 10.3390/metabo7040062
  contributor:
    fullname: J Chong
– volume: 38
  start-page: 1031
  year: 2019
  ident: 327_CR24
  publication-title: Clin. Nutr.
  doi: 10.1016/j.clnu.2018.05.018
  contributor:
    fullname: OR Tamtaji
– volume: 11
  year: 2010
  ident: 327_CR86
  publication-title: BMC Bioinforma.
  doi: 10.1186/1471-2105-11-119
  contributor:
    fullname: D Hyatt
– volume: 21
  start-page: 289
  year: 2018
  ident: 327_CR28
  publication-title: Arch. Iran. Med.
  contributor:
    fullname: S Borzabadi
– volume: 89
  start-page: 546
  year: 2021
  ident: 327_CR57
  publication-title: Ann. Neurol.
  doi: 10.1002/ana.25982
  contributor:
    fullname: AH Tan
– volume: 114
  start-page: 429
  year: 2021
  ident: 327_CR45
  publication-title: Am. J. Clin. Nutr.
  doi: 10.1093/ajcn/nqab078
  contributor:
    fullname: X Zhang
– volume: 15
  start-page: 17
  year: 2020
  ident: 327_CR27
  publication-title: PLos ONE
  contributor:
    fullname: A Ibrahim
– volume: 10
  year: 2020
  ident: 327_CR21
  publication-title: Amb. Express
  doi: 10.1186/s13568-020-01014-6
  contributor:
    fullname: X Fang
– volume: 23
  start-page: 1707
  year: 2008
  ident: 327_CR71
  publication-title: Mov. Disord.
  doi: 10.1002/mds.22197
  contributor:
    fullname: CA Haaxma
– volume: 78
  start-page: 577
  year: 2020
  ident: 327_CR11
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2020.03.006
  contributor:
    fullname: KG Jameson
– volume: 87
  start-page: 1274
  year: 2016
  ident: 327_CR23
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000003127
  contributor:
    fullname: M Barichella
– volume: 182
  start-page: 1460
  year: 2020
  ident: 327_CR44
  publication-title: Cell
  doi: 10.1016/j.cell.2020.08.007
  contributor:
    fullname: RAT Mars
– volume: 473
  start-page: 174
  year: 2011
  ident: 327_CR50
  publication-title: Nature
  doi: 10.1038/nature09944
  contributor:
    fullname: M Arumugam
– volume: 574
  start-page: 686
  year: 2019
  ident: 327_CR65
  publication-title: Nature
  doi: 10.1038/s41586-019-1688-z
  contributor:
    fullname: G Faraco
– volume: 30
  start-page: 1591
  year: 2015
  ident: 327_CR69
  publication-title: Mov. Disord.
  doi: 10.1002/mds.26424
  contributor:
    fullname: RB Postuma
– volume: 24
  start-page: 30
  year: 2018
  ident: 327_CR1
  publication-title: J. Neurogastroenterol. Motil.
  doi: 10.5056/jnm17105
  contributor:
    fullname: AT Nair
– volume: 65
  start-page: 57
  year: 2016
  ident: 327_CR46
  publication-title: Gut
  doi: 10.1136/gutjnl-2015-309618
  contributor:
    fullname: D Vandeputte
– volume: 318
  start-page: G361
  year: 2020
  ident: 327_CR61
  publication-title: Am. J. Physiol.Gastrointest. Liver Physiol.
  doi: 10.1152/ajpgi.00283.2019
  contributor:
    fullname: M Muller
– volume: 7
  start-page: 13
  year: 2019
  ident: 327_CR79
  publication-title: Peerj
  contributor:
    fullname: DWD Kang
– volume: 10
  start-page: 1025
  year: 2016
  ident: 327_CR87
  publication-title: ISME J.
  doi: 10.1038/ismej.2015.188
  contributor:
    fullname: Y Darzi
– volume: 7
  start-page: 13
  year: 2021
  ident: 327_CR7
  publication-title: Npj Parkinsons Dis.
  doi: 10.1038/s41531-021-00156-z
  contributor:
    fullname: S Romano
– volume: 364
  start-page: 9
  year: 2017
  ident: 327_CR68
  publication-title: Fems Microbiol. Lett.
  contributor:
    fullname: J Kreit
– volume: 63
  start-page: 8
  year: 2019
  ident: 327_CR49
  publication-title: Mol. Nutr. Food Res.
  doi: 10.1002/mnfr.201801012
  contributor:
    fullname: A Kaur
– volume: 20
  year: 2021
  ident: 327_CR76
  publication-title: Microb. Cell Factories
  doi: 10.1186/s12934-021-01589-0
  contributor:
    fullname: XY Kuai
– volume: 9
  start-page: 1354
  year: 2018
  ident: 327_CR60
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2018.01354
  contributor:
    fullname: W Feng
– volume: 6
  start-page: 12
  year: 2020
  ident: 327_CR5
  publication-title: Npj Parkinsons Dis.
  doi: 10.1038/s41531-020-0112-6
  contributor:
    fullname: ZD Wallen
– volume: 12
  start-page: 4010
  year: 2020
  ident: 327_CR40
  publication-title: Aging
  doi: 10.18632/aging.102810
  contributor:
    fullname: HY Deng
– volume: 361
  start-page: 1268
  year: 2009
  ident: 327_CR37
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa0809335
  contributor:
    fullname: CW Olanow
– volume: 12
  start-page: 9
  year: 2021
  ident: 327_CR56
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-021-21669-4
  contributor:
    fullname: E Sinclair
– volume: 49
  start-page: 1111
  year: 2017
  ident: 327_CR64
  publication-title: Amino Acids
  doi: 10.1007/s00726-017-2409-2
  contributor:
    fullname: A Haghikia
– volume: 10
  start-page: 206
  year: 2020
  ident: 327_CR20
  publication-title: Brain Sci.
  doi: 10.3390/brainsci10040206
  contributor:
    fullname: T-H Hsieh
– volume: 20
  year: 2019
  ident: 327_CR38
  publication-title: Trials
  doi: 10.1186/s13063-019-3389-1
  contributor:
    fullname: PD Browne
– volume: 25
  start-page: 1043
  year: 2015
  ident: 327_CR82
  publication-title: Genome Res.
  doi: 10.1101/gr.186072.114
  contributor:
    fullname: DH Parks
– volume: 167
  start-page: 1469
  year: 2016
  ident: 327_CR10
  publication-title: Cell
  doi: 10.1016/j.cell.2016.11.018
  contributor:
    fullname: TR Sampson
– volume: 96
  start-page: E772
  year: 2021
  ident: 327_CR25
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000011652
  contributor:
    fullname: AH Tan
– volume: 37
  start-page: 183
  year: 2011
  ident: 327_CR74
  publication-title: Neuroepidemiology
  doi: 10.1159/000331911
  contributor:
    fullname: T Mueller
– volume: 10
  start-page: 11
  year: 2019
  ident: 327_CR14
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-018-07826-2
  contributor:
    fullname: SP van Kessel
– volume: 25
  start-page: 2078
  year: 2009
  ident: 327_CR81
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp352
  contributor:
    fullname: H Li
– volume: 38
  start-page: 2053
  year: 2019
  ident: 327_CR42
  publication-title: Clin. Nutr.
  doi: 10.1016/j.clnu.2018.09.010
  contributor:
    fullname: LC Lew
– volume: 226
  start-page: 22
  year: 2021
  ident: 327_CR62
  publication-title: Pharmacol. Therapeutics
  doi: 10.1016/j.pharmthera.2021.107861
  contributor:
    fullname: XY Mao
– volume: 150
  start-page: 1481
  year: 2016
  ident: 327_CR70
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2016.02.014
  contributor:
    fullname: OS Palsson
– volume: 1
  start-page: 666
  year: 2021
  ident: 327_CR12
  publication-title: Food Behav. Res.
  contributor:
    fullname: M Boehme
– volume: 13
  start-page: 676827
  year: 2021
  ident: 327_CR18
  publication-title: Front. Aging Neurosci.
  doi: 10.3389/fnagi.2021.676827
  contributor:
    fullname: X Wen
– volume: 364
  start-page: 1055
  year: 2019
  ident: 327_CR13
  publication-title: Science
  contributor:
    fullname: VM Rekdal
– volume: 24
  start-page: 257
  year: 2009
  ident: 327_CR51
  publication-title: Metab. Brain Dis.
  doi: 10.1007/s11011-009-9139-4
  contributor:
    fullname: EF dos Santos
– volume: 372
  start-page: 279
  year: 2003
  ident: 327_CR63
  publication-title: Biochem. J.
  doi: 10.1042/bj20030002
  contributor:
    fullname: L Caldovic
– volume: 319
  start-page: G529
  year: 2020
  ident: 327_CR2
  publication-title: Am. J. Physiol. Gastrointest. Liver Physiol.
  doi: 10.1152/ajpgi.00058.2020
  contributor:
    fullname: Y Bhattarai
– volume: 11
  start-page: 2864
  year: 2017
  ident: 327_CR84
  publication-title: Isme J.
  doi: 10.1038/ismej.2017.126
  contributor:
    fullname: MR Olm
– volume: 11
  start-page: 1386
  year: 2018
  ident: 327_CR54
  publication-title: Mucosal Immunol.
  doi: 10.1038/s41385-018-0042-3
  contributor:
    fullname: HM Jang
– volume: 29
  start-page: 394
  year: 2021
  ident: 327_CR48
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2020.12.012
  contributor:
    fullname: C Tanes
– volume: 45
  start-page: 2252
  year: 2021
  ident: 327_CR66
  publication-title: Int. J. Obes.
  doi: 10.1038/s41366-021-00888-1
  contributor:
    fullname: E Handakas
– volume: 10
  year: 2019
  ident: 327_CR88
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-019-10927-1
  contributor:
    fullname: H Mallick
– volume: 15
  start-page: 80
  year: 2016
  ident: 327_CR39
  publication-title: Nutr. J.
  doi: 10.1186/s12937-016-0198-1
  contributor:
    fullname: L Otstlund-Lagerstrom
– volume: 11
  start-page: 1601
  year: 2016
  ident: 327_CR26
  publication-title: Clin. Interven. Aging
  doi: 10.2147/CIA.S106284
  contributor:
    fullname: D Georgescu
– volume: 11
  year: 2021
  ident: 327_CR53
  publication-title: Transl. Psychiatry
  doi: 10.1038/s41398-021-01309-7
  contributor:
    fullname: EE Noble
– volume: 60
  start-page: 3757
  year: 2021
  ident: 327_CR30
  publication-title: Eur. J. Nutr.
  doi: 10.1007/s00394-021-02543-x
  contributor:
    fullname: JN Cao
– volume: 4
  start-page: 396
  year: 2019
  ident: 327_CR15
  publication-title: Nat. Microbiol.
  doi: 10.1038/s41564-018-0307-3
  contributor:
    fullname: P Strandwitz
– volume: 118
  start-page: 8
  year: 2021
  ident: 327_CR67
  publication-title: Proc. Natl Acad. Sci. USA
  contributor:
    fullname: J Kobayashi
– volume: 4
  start-page: 623
  year: 2019
  ident: 327_CR32
  publication-title: Nat. Microbiol.
  doi: 10.1038/s41564-018-0337-x
  contributor:
    fullname: M Valles-Colomer
– volume: 44
  start-page: 691
  year: 2019
  ident: 327_CR47
  publication-title: Ebiomedicine
  doi: 10.1016/j.ebiom.2019.05.064
  contributor:
    fullname: VTE Aho
– volume: 74
  start-page: 720
  year: 2013
  ident: 327_CR77
  publication-title: Biol. Psychiatry
  doi: 10.1016/j.biopsych.2013.05.001
  contributor:
    fullname: TG Dinan
– volume: 57
  start-page: 117
  year: 2011
  ident: 327_CR22
  publication-title: Minerva Gastroenterol. Dietol.
  contributor:
    fullname: E Cassani
– volume: 6
  start-page: 20
  year: 2021
  ident: 327_CR35
  publication-title: Signal Transduct. Target. Ther.
  doi: 10.1038/s41392-020-00357-7
  contributor:
    fullname: Y Wang
– volume: 76
  start-page: 32
  year: 2021
  ident: 327_CR41
  publication-title: J. Gerontol. Ser. A Biol. Sci. Med. Sci.
  doi: 10.1093/gerona/glaa090
  contributor:
    fullname: CS Kim
– volume: 35
  start-page: 1208
  year: 2020
  ident: 327_CR6
  publication-title: Mov. Disord.
  doi: 10.1002/mds.28052
  contributor:
    fullname: MS Cirstea
– volume: 77
  start-page: 427
  year: 2020
  ident: 327_CR58
  publication-title: JAMA Neurol.
  doi: 10.1001/jamaneurol.2019.4611
  contributor:
    fullname: S Mullin
– volume: 675
  start-page: 116
  year: 2018
  ident: 327_CR59
  publication-title: Neurosci. Lett.
  doi: 10.1016/j.neulet.2018.03.064
  contributor:
    fullname: SA Crooks
– volume: 16
  year: 2021
  ident: 327_CR3
  publication-title: Mol. Neurodegeneration
  doi: 10.1186/s13024-021-00439-2
  contributor:
    fullname: M Gries
– volume: 5
  start-page: 51
  year: 2016
  ident: 327_CR4
  publication-title: Curr. Obes. Rep.
  doi: 10.1007/s13679-016-0191-1
  contributor:
    fullname: J Ochoa-Reparaz
– volume: 3
  start-page: 9
  year: 2017
  ident: 327_CR36
  publication-title: Npj Parkinsons Dis.
  doi: 10.1038/s41531-016-0002-0
  contributor:
    fullname: MC Houser
– volume: 99
  start-page: 1877
  year: 2019
  ident: 327_CR8
  publication-title: Physiol. Rev.
  doi: 10.1152/physrev.00018.2018
  contributor:
    fullname: JF Cryan
– volume: 20
  start-page: 181
  year: 2020
  ident: 327_CR75
  publication-title: BMC Geriatr.
  doi: 10.1186/s12877-020-01574-z
  contributor:
    fullname: G Gefenaite
– volume: 14
  start-page: 10
  year: 2021
  ident: 327_CR43
  publication-title: Neurobiol. Stress
  doi: 10.1016/j.ynstr.2021.100294
  contributor:
    fullname: T Ma
– volume: 94
  start-page: 33
  year: 2014
  ident: 327_CR52
  publication-title: Protein Expr. Purif.
  doi: 10.1016/j.pep.2013.10.018
  contributor:
    fullname: K Zhang
– volume: 103
  start-page: 8791
  year: 2020
  ident: 327_CR29
  publication-title: J. Dairy Sci.
  doi: 10.3168/jds.2019-18049
  contributor:
    fullname: W Zhang
– volume: 140
  start-page: 11
  year: 2021
  ident: 327_CR16
  publication-title: Biomed. Pharmacother.
  contributor:
    fullname: XY Zhao
– volume: 245
  start-page: 10
  year: 2020
  ident: 327_CR17
  publication-title: Life Sci.
  doi: 10.1016/j.lfs.2020.117345
  contributor:
    fullname: YS Feng
– volume: 20
  year: 2019
  ident: 327_CR85
  publication-title: Genome Biol.
  doi: 10.1186/s13059-019-1891-0
  contributor:
    fullname: DE Wood
– volume: 116
  start-page: 3774
  year: 2019
  ident: 327_CR55
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1819154116
  contributor:
    fullname: K Unterhauser
– volume: 287
  start-page: 36
  year: 2009
  ident: 327_CR73
  publication-title: J. Neurol. Sci.
  doi: 10.1016/j.jns.2009.09.015
  contributor:
    fullname: Y Uemura
SSID ssj0001468950
Score 2.477037
Snippet Parkinson’s disease (PD) is mainly managed by pharmacological therapy (e.g., Benserazide and dopamine agonists). However, prolonged use of these drugs would...
Parkinson's disease (PD) is mainly managed by pharmacological therapy (e.g., Benserazide and dopamine agonists). However, prolonged use of these drugs would...
Abstract Parkinson’s disease (PD) is mainly managed by pharmacological therapy (e.g., Benserazide and dopamine agonists). However, prolonged use of these drugs...
Abstract Parkinson’s disease (PD) is mainly managed by pharmacological therapy (e.g., Benserazide and dopamine agonists). However, prolonged use of these drugs...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 62
SubjectTerms 692/617/375/1718
692/699/375/365/1718
Biomedical and Life Sciences
Biomedicine
Dopamine
Neurology
Neurosciences
Parkinson's disease
Probiotics
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NattAEB6CDyWXkqZNotQJW-gtWSxp_6RjUhJMIaWFGnxb5NUu9cFKiO1Dcupr9PXyJJlZya7dH3op6KTdw2hmlvlGs_MNwHstS4NxRvFKKcOlCI5X0gleIhrJzCTLTKB-55tPejiSH8dqvDHqi-6EtfTAreIGtXFCa6nRFZ0MoSorPfFUXEOoLWrTQqO03Eim4t8VqYtSpV2XTCqKwRwjlcDMGXMvdOTccL0ViSJh_59Q5u-XJX-pmMZAdL0HLzsEyS5ayV_Bjm_24cVNVyN_DV8-R2olol9m8wdq7Zs--prRD1e2ecec0UyGmW_YtGGzbloRoybo2A_29P3HnHXVmzcwur76-mHIu8EJ3CEAW_DgiVfOY2omslqa4IWZSF076dO81j4YYqnD2JVhpMocfpmsQqFD0M5Q-iHFAfSa28YfAROBJtELVedFJRFslTJLncLdlFerKiRwtlKivWv5MWysa4vCtiq3qHIbVW51Apek5_VO4raOL9DitrO4_ZfFE-ivrGS7Aze3iDMKhY8SCbxbL-NRofpH1fjbZdyDPpEjoEzgsDXqWhJBODIXKKHZMveWqNsrzfRbpOMuqfZbmgTOV47xU6y_q-L4f6jiLezm0aMVz2Ufeov7pT9BkLSYnMbz8AxTiwxs
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LbxQxDLZgKyEuqLwHCgoSN4g6M3nNnKoWtaqQWhVEpd6ibCahe-hs6WwPcOJv8Pf4JbWz2V2WlzSnSQ6O7cR2vtgGeK1la9DOKO6UMlyK6LmTXvAWvZHKjKvKRMp3PjrWh6fy_Zk6yxduQ35WuTgT00HdTT3dkW-jIWkUfkrsXH7h1DWK0NXcQuM2bNQYKZQj2NjbPz75uLplkbppVZmzZUrRbA9osQRG0BiDoULXhus1i5QK9__N2_zz0eRvyGkySAebcC97kmx3Lvr7cCv0D-DOUcbKH8KHk1Riicows-ErpfhNvoWO0cUr-_WtOaPeDBehZ5OeXeSuRYySoVNe2M_vPwaWUZxHcHqw_-ndIc8NFLhHR2zGY6D6cgFDNFF10sQgzFjqzstQ1p0O0VC1OrRhFVqsyuPKpIuNjlF7Q2GIFI9h1E_78BSYiNSRXqiubpxEp6uVVekVzqb4WrlYwJsFE-3lvE6GTfi2aOyc5RZZbhPLrS5gj_i8nEk1rtOP6dVnm7eM7YwXWkuNh5CXMbrW6XEgWBWDLNEZV8DWQko2b7zBrtSkgFfLYdwyhIO4Pkyv0xzUiRodywKezIW6pESQP1kLpNCsiXuN1PWRfnKeynK3hAG3poC3C8VYkfVvVjz7_yqew9066aritdyC0ezqOrxAN2g2fpl1_QabTAWG
  priority: 102
  providerName: ProQuest
– databaseName: SpringerOpen
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NTtwwEB4VKiEuqJRCQ6FyJW6txSb-S47tqghVoioSSNwsr2OLPRBQdznAidfg9XgSZrzepWnhUCmnZCI5M-PMNx7PZ4A9LRuDcUZxp5ThUkTPnfSCN4hGSjMqSxOp3_nopz48lT_O1FmmyaFemF79XtT7EwwwAhNeTJnQ_yrD9RK8xhhc0_atoR4-radIXTdqkPtinn-1F3sSRf9zuPLf7ZF_1UhT6Dl4A2sZM7KvMyOvw6vQvYWVo1wV34DjX4lMiQiX2eSGmvnGt6FltMTK_txVzugUhovQsXHHLvL5RIzanlMH2MPd_YTles07OD34fjI85PmoBO4Rck15DMQkFzAZE2UrTQzCjKRuvQyDqtUhGuKlw2hVYmwqPX6ZdLHWMWpvKOGQYhOWu8suvAcmIp09L1Rb1U4ivGpkOfAKpSmTVi4W8HmuRHs1Y8SwqZItajtTuUWV26Ryqwv4RnpeSBKbdbqBRrZ5ctjWeKG11Pi78TJG1zg9ClRAxXRKtMYVsDO3ks1TbGIRWdQKLyUK-LR4jJODKh6uC5fXSQZ9okIIWcDWzKiLkQhCjpXAEZqeuXtD7T_pxueJgLuham9jCvgyd4ynYb2siu3_E_8Aq1XyXcUruQPL09_XYRcB0HT0MXn-I7pR_M8
  priority: 102
  providerName: Springer Nature
Title Probiotics synergized with conventional regimen in managing Parkinson’s disease
URI https://link.springer.com/article/10.1038/s41531-022-00327-6
https://www.ncbi.nlm.nih.gov/pubmed/35610236
https://www.proquest.com/docview/2668568553
https://search.proquest.com/docview/2669502059
https://pubmed.ncbi.nlm.nih.gov/PMC9130297
https://doaj.org/article/d7c36646073c4ffa9a6be38915483d7a
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEB6SFEovpe8qTcwWemsVW9qXdHRMQjA4uI-Ab8tqtZsaajnEziE99W_07_WXZHa9cuI2uRQMAmnBq9lZzTc7M98AfBCslGhneKo5lymjzqSaGZqWiEYyWWWZdL7eeXQqTs7YcMInW8DbWpiQtG-q6UHzY3bQTL-H3MqLmem2eWLd8WhQ-mhbKbvbsI0KesdFDwcrTBQl78UCmR4tugs0UhSdZnS7UIdzmfq-RdQDhzwwM9_ao0Dbfx_W_Ddl8q-4aTBHx8_gacSRpL-a73PYss0LeDyKkfKX8HkcCJY8CTNZXPsCv-lPWxN_7EruZpoT35lhZhsybcgs9iwivhQ6VIX9-fV7QWIM5xWcHR99G5yksX1CahCGLVNnPbucRQeNZjWTzlJZMVEbZnt5LayTnqsOLViG9ioz-GZMu0I4J4z0Tgijr2GnmTf2LRDqfD96yuu80AwhV8mynuE42nvXXLsEPrZCVBcrlgwVotu0UCvpK5S-CtJXIoFDL-f1SM9wHW7ML89VXGdVS0OFYAI_QYY5p0stKuuDquhi0VrqBPbaVVJx2y0Uoo2C44_TBN6vH-OG8VEQ3dj5VRiD6pEjrEzgzWpR1zNplSIBubHcG1PdfII6Gki5o04m8KlVjNtpPSyK3f_-o3fwJA8azdOc7cHO8vLK7iM-WlYd3BUT2YFH_f7w6xCvh0en4y94dyAGnXDm0Ak75gaTURLe
link.rule.ids 230,315,730,783,787,867,888,2109,12068,21400,27936,27937,31731,31732,33756,33757,41132,42201,43322,43817,51588,53804,53806,74079,74636
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LbxMxEB5BkYAL4s1CASNxA6vZ9Wv3hABRBWgqkFopN8vx2iWHbtpueign_gZ_j1_CjOMkhJe0p7UP45mxZ8bj-QbguZaNQTujuFPKcCmi5056wRv0RkozKUsTqd55tK-Hh_LDWI3zhVufn1Uuz8R0ULczT3fkO2hIaoWfEq9OTjl1jaLsam6hcRmuEA4XdTAwY7O-Y5G6btQg18oMRL3To70SGD9jBIbqXBmuN-xRgu3_m6_555PJ3_KmyRzt3oQb2Y9krxeCvwWXQncbro5ypvwOfP6UAJYIhJn1F1TgN_0aWkbXruzXl-aMOjMch45NO3acexYxKoVOVWE_vn3vWc7h3IXD3XcHb4c8t0_gHt2wOY-B0OUCBmiibKWJQZiJ1K2XYVC1OkRDWHVowUq0V6XHlUkXax2j9oaCECnuwVY368IDYCJSP3qh2qp2El2uRpYDr3A2RdfKxQJeLJloTxYoGTZlt0VtFyy3yHKbWG51AW-Iz6uZhHCdfszOjmzeMLY1XmgtNR5BXsboGqcngZKqGGKJ1rgCtpdSsnnb9XatJAU8Ww3jhqEsiOvC7DzNQZ2o0K0s4P5CqCtKBHmTlUAKzYa4N0jdHOmmXxIod0MZ4MYU8HKpGGuy_s2Kh_9fxVO4NjwY7dm99_sfH8H1Kumt4pXchq352Xl4jA7RfPIkaf1PpbMHEQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LbxMxEB5BkSouiDdbChiJG1jJrl-7J8QrKo9WRaJSbpbjtUsO3ZRueign_gZ_j1_CjOMkhJe0p7UP4_Fnz4znBfBEy8agnFHcKWW4FNFzJ73gDWojpZmUpYmU77x_oPeO5LuxGuf4pz6HVS7vxHRRtzNPb-QDFCS1wk-JQcxhEYevR89Pv3DqIEWe1txO4zJcMWilEMLN2KzfW6SuGzXMeTNDUQ96lF0CbWm0xhDaleF6QzalEv5_0zv_DJ_8zYeaRNPoOlzLOiV7sQDBDbgUupuwvZ-95rfg42EqtkQFmVl_Qcl-06-hZfQEy36NOmfUpeEkdGzasZPcv4hRWnTKEPvx7XvPsj_nNhyN3nx6tcdzKwXuUSWb8xio0lxAY02UrTQxCDORuvUyDKtWh2iobh1KsxJlV-lxZdLFWseovSGDRIo7sNXNunAPmIjUm16otqqdRPWrkeXQK5xNlrZysYCnSyba00XFDJs83aK2C5ZbZLlNLLe6gJfE59VMqnadfszOjm0-PLY1XmgtNV5HXsboGqcngRysaG6J1rgCdpe7ZPMR7O0aMAU8Xg3j4SGPiOvC7DzNQUxUqGIWcHexqStKBGmWlUAKzcZ2b5C6OdJNP6cC3Q15gxtTwLMlMNZk_ZsVO_9fxSPYRsDbD28P3t-Hq1WCreKV3IWt-dl5eIC60XzyMIH-JyzmC08
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Probiotics+synergized+with+conventional+regimen+in+managing+Parkinson%27s+disease&rft.jtitle=NPJ+Parkinson%27s+Disease&rft.au=Sun%2C+Hairong&rft.au=Zhao%2C+Feiyan&rft.au=Liu%2C+Yuanyuan&rft.au=Ma%2C+Teng&rft.date=2022-05-24&rft.issn=2373-8057&rft.eissn=2373-8057&rft.volume=8&rft.issue=1&rft.spage=62&rft.epage=62&rft_id=info:doi/10.1038%2Fs41531-022-00327-6&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2373-8057&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2373-8057&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2373-8057&client=summon